Your browser doesn't support javascript.
loading
Locoregional recurrence in skin-sparing and nipple-sparing mastectomies.
Costeira, Beatriz; da Silva, Francisca B; Oom, Rodrigo; Costa, Cristina; Moniz, João V; Abecasis, Nuno; Santos, Catarina R.
Afiliação
  • Costeira B; Breast Surgery Unit, Department of General Surgery, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
  • da Silva FB; Breast Surgery Unit, Department of General Surgery, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
  • Oom R; Breast Surgery Unit, Department of General Surgery, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
  • Costa C; Breast Surgery Unit, Department of General Surgery, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
  • Moniz JV; Breast Surgery Unit, Department of General Surgery, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
  • Abecasis N; Breast Surgery Unit, Department of General Surgery, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
  • Santos CR; Breast Surgery Unit, Department of General Surgery, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
J Surg Oncol ; 125(3): 352-360, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34687468
ABSTRACT

BACKGROUND:

Skin- and nipple-sparing mastectomies (SSMs/NSMs) present as an alternative for patients requiring mastectomy, with better aesthetic results. We aimed to evaluate the locoregional recurrence (LRR) rate and its predictive factors.

METHODS:

Retrospective analysis of all consecutive cases of SSM and NSM for a primary diagnosis of in situ or invasive breast cancer, at a national cancer center, from January 1st, 2013 to May 31st, 2019. The primary outcome was LRR. Secondary outcomes included LRR predictive factors, overall survival (OS), and disease-free survival (DFS).

RESULTS:

There were included 461 patients; 402 (87%) with invasive carcinoma. The median age was 46 (interquartile range [IQR] 40-53) years. Ninety (20%) patients had locally advanced disease. LRR rate was 3.0%, with a median follow-up time of 39 (IQR 21-59) months. The median time to recurrence was 22 (IQR 10-45) months. Factors independently associated with LRR were high histological grade, negative estrogen receptor status, and high Ki67 (p < 0.05). OS was 94.8% and DFS was 92.8%. LRR was associated with decreased OS.

DISCUSSION:

SSM and NSM present as a safe approach to breast cancer requiring mastectomy, including selected patients with a locally advanced tumor. The associated LRR rate is 3.0%, with risk factors being high grade, negative estrogen receptor status, and high Ki67.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma / Mastectomia Simples / Mastectomia Subcutânea / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma / Mastectomia Simples / Mastectomia Subcutânea / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article